Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Financial Advisor

<< Previous

Bullboard Posts

Next >>

Comment by CAinPlapon Sep 20, 2023 5:07pm

200 Views

Post# 35646204

RE:RE:Financial Advisor

I think the reason we are not yet thinking of using prior to patients being treated with BCG is that we would require an expensive phase 3 trial to compare our treatment to treating with BCG. Our current trial does not require a phase 3 as there is no standard to compare against.

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management